SEGMENT INFORMATION (Tables)

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Schedule of segment revenues and profit

Segment revenues and profits were as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
(in millions)	2020		2019		2020		2019
Revenues:
Bausch + Lomb/International	$	883	$	1,208	$	1,997	$	2,326
Salix	404		509		881		954
Ortho Dermatologics	116		122		249		260
Diversified Products	261		313		549		628
	$	1,664	$	2,152	$	3,676	$	4,168
Segment profits:
Bausch + Lomb/International	$	169	$	337	$	494	$	656
Salix	289		332		608		620
Ortho Dermatologics	38		41		86		98
Diversified Products	184		232		386		468
	680		942		1,574		1,842
Corporate	(145)		(152)		(301)		(277)
Amortization of intangible assets	(436)		(488)		(872)		(977)
Asset impairments	(1)		(13)		(15)		(16)
Restructuring and integration costs	(7)		(4)		(11)		(24)
Acquisition-related contingent consideration	(11)		(20)		(24)		1
Other expense, net	(107)		(8)		(130)		(5)
Operating (loss) income	(27)		257		221		544
Interest income	2		3		9		7
Interest expense	(385)		(409)		(781)		(815)
Loss on extinguishment of debt	(27)		(33)		(51)		(40)
Foreign exchange and other	—		3		(13)		3
Loss before benefit from income taxes	$	(437)	$	(179)	$	(615)	$	(301)

Schedule of revenues by segment and product category

Revenues by segment and product category were as follows:

	Three Months Ended June 30, 2020										Three Months Ended June 30, 2019
(in millions)	Bausch + Lomb/ International		Salix		Ortho Dermatologics		Diversified Products		Total		Bausch + Lomb/ International		Salix		Ortho Dermatologics		Diversified Products		Total
Pharmaceuticals	$	151	$	403	$	71	$	158	$	783	$	235	$	509	$	75	$	199	$	1,018
Devices	220		—		42		—		262		387		—		45		—		432
OTC	318		—		—		—		318		367		—		—		—		367
Branded and Other Generics	175		—		—		99		274		194		—		—		111		305
Other revenues	19		1		3		4		27		25		—		2		3		30
	$	883	$	404	$	116	$	261	$	1,664	$	1,208	$	509	$	122	$	313	$	2,152

	Six Months Ended June 30, 2020										Six Months Ended June 30, 2019
(in millions)	Bausch + Lomb/ International		Salix		Ortho Dermatologics		Diversified Products		Total		Bausch + Lomb/ International		Salix		Ortho Dermatologics		Diversified Products		Total
Pharmaceuticals	$	352	$	880	$	148	$	340	$	1,720	$	452	$	954	$	170	$	410	$	1,986
Devices	561		—		93		—		654		753		—		83		—		836
OTC	669		—		—		—		669		691		—		—		—		691
Branded and Other Generics	378		—		—		202		580		385		—		—		213		598
Other revenues	37		1		8		7		53		45		—		7		5		57
	$	1,997	$	881	$	249	$	549	$	3,676	$	2,326	$	954	$	260	$	628	$	4,168

Schedule of revenue attributed to a geographic region

Revenues are attributed to a geographic region based on the location of the customer and were as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
(in millions)	2020		2019		2020		2019
U.S. and Puerto Rico	$	1,009	$	1,282	$	2,221	$	2,482
China	79		101		137		190
Canada	67		88		157		167
Egypt	58		49		116		102
Japan	48		59		102		114
Mexico	48		60		89		106
France	42		58		89		111
Poland	37		53		111		115
Germany	32		41		76		86
Russia	24		41		57		77
South Korea	16		18		33		35
Other	204		302		488		583
	$	1,664	$	2,152	$	3,676	$	4,168

Schedule of customers that accounted for 10% or more of total revenue

Customers that accounted for 10% or more of total revenues were as follows:

	Six Months Ended June 30,
	2020	2019
AmerisourceBergen Corporation	18%	16%
McKesson Corporation (including McKesson Specialty)	17%	17%
Cardinal Health, Inc.	13%	14%